Showing results (231-240 of 470) with videos related to
Sort By:
Pageof 47
Cancers|May 28, 2020
WRN-Mutated Colorectal Cancer Is Characterized by a Distinct Genetic PhenotypeKai Zimmer, Alberto Puccini, Joanne Xiu, et al.NPJ Breast Cancer|January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston, Miguel Martin, Angelo Di Leo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerMatthew P Goetz, David Toft, Joel Reid, et al.Journal of the American Medical Informatics Association : JAMIA|December 6, 2011
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical recordGuergana K Savova, Janet E Olson, Sean P Murphy, et al.Breast Cancer Research and Treatment|January 21, 2018
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG)Jame Abraham, Humberto Caldera, Robert Coleman, et al.Nature Communications|November 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01Salvatore Siena, Kanwal Raghav, Toshiki Masuishi, et al.JCO Precision Oncology|March 23, 2022
Landscape of KRASG12C, Associated Genomic Alterations, and Interrelation With Immuno-Oncology Biomarkers in KRAS-Mutated CancersMohamed E Salem, Sherif M El-Refai, Wei Sha, et al.The Oncologist|January 18, 2007
The continuum of care: a paradigm for the management of metastatic colorectal cancerRichard M Goldberg, Mace L Rothenberg, Eric Van Cutsem, et al.European Journal of Cancer (Oxford, England : 1990)|January 19, 2024
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluationRomain Cohen, Morteza Raeisi, Benoist Chibaudel, et al.Retina (Philadelphia, Pa.)|July 14, 2012
A factor found in the IgG fraction of serum of patients with paraneoplastic bilateral diffuse uveal melanocytic proliferation causes proliferation of cultured human melanocytesSarah L Miles, Richard M Niles, Sean Pittock, et al.Pageof 47